Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604039 · ClinicalTrials.gov registry record
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
A clinical trial of Vascular Access Device, sponsored by Teleflex.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 3
- Study locations
NCT06604039 is a study of Vascular Access Device that is actively recruiting participants, run by Teleflex. The registered enrollment target is 2,500 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT06604039, a study of Vascular Access Device, is actively recruiting participants, sponsored by Teleflex.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 3
- Study locations
Study Summary
The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
Conditions Studied
Interventions
- DEVICE Central venous catheter
Study Locations (3)
Alabama
- Huntsville Hospital - Huntsville
California
- Loma Linda University Health - Loma Linda
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2024-12-08 |
| Est. Completion | 2034-12-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06604039
The ClinicalTrials.gov registry entry for NCT06604039 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teleflex, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vascular Access Device appearing as the primary indexed condition, and to 1 intervention - of which Central venous catheter is the first listed.
NCT06604039 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06604039 about?
NCT06604039 is a clinical study titled "A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices". The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
What is the current status of trial NCT06604039?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2024-12-08. Estimated completion is 2034-12-07.
What conditions does trial NCT06604039 study?
This clinical trial studies the following conditions: Vascular Access Device.
What interventions are being tested in trial NCT06604039?
The interventions under investigation include: Central venous catheter (DEVICE).
Who is sponsoring clinical trial NCT06604039?
This trial is sponsored by Teleflex, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06604039 being conducted?
This trial has 3 study locations across Alabama, California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.